Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2020
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemiaAdam J Lamble, Yoko Kosaka, Ted Laderas, et al.Blood|February 26, 2025
A CEBPB/IL-1β/TNF-α feedback loop drives drug resistance to venetoclax and MDM2 inhibitors in monocytic leukemiaBasil Allen, Daniel Bottomly, Thomas Köhnke, et al.Blood Cancer Discovery|May 21, 2025
Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN studyCurtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena, et al.Cancer Cell|June 25, 2021
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistanceSunil K Joshi, Tamilla Nechiporuk, Daniel Bottomly, et al.Blood Neoplasia|April 20, 2026
Results of a phase 1 trial testing ruxolitinib plus venetoclax in patients with relapsed/refractory acute myeloid leukemiaUma Borate, Cristina E Tognon, Yazan F Madanat, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk ModelCurtis A Lachowiez, Joshua F Zeidner, Jad Othman, et al.Nature|October 19, 2018
Functional genomic landscape of acute myeloid leukaemiaJeffrey W Tyner, Cristina E Tognon, Daniel Bottomly, et al.Cancer Cell|July 22, 2022
Integrative analysis of drug response and clinical outcome in acute myeloid leukemiaDaniel Bottomly, Nicola Long, Anna Reister Schultz, et al.Pageof 4